RMD Open

ISSN: 2056-5933
Publisher: BMJ Publishing Group

Publications (29)


Types of publications

Journal article
Unpublished / Preprint

Publication year



Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage (2024) Zabotti A, Fagni F, Gossec L, Giovannini I, Sticherling M, Tullio A, Baraliakos X, et al. Journal article Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry (2024) Kuemmerle-Deschner JB, Kallinich T, Henes J, Kortus-Götze B, Oommen PT, Rech J, Krickau T, et al. Journal article, Original article Metabolic and molecular imaging in inflammatory arthritis (2024) de Sousa RN, Tascilar K, Corte G, Atzinger A, Minopoulou I, Ohrndorf S, Waldner M, et al. Journal article, Review article Tolerability of low to moderate biomechanical stress during leisure sport activity in patients with psoriasis and psoriatic arthritis (2023) Fagni F, Mutlu MY, Temiz SA, Minopoulou I, Krieter M, Schett G, Kleyer A, et al. Journal article Quality of citation data using the natural language processing tool ChatGPT in rheumatology: Creation of false references (2023) Hueber AJ, Kleyer A Journal article Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA. (2023) Regierer AC, Weiß A, Proft F, Baraliakos X, Behrens F, Poddubnyy D, Schett G, et al. Journal article Antibodies against citrullinated proteins of IgA isotype are associated with progression to rheumatoid arthritis in individuals at-risk. (2023) Sokolova M, Hartmann F, Sieghart D, Bang H, Steiner G, Kleyer A, Schett G, Steffen U Journal article Daratumumab for the treatment of refractory ANCA-associated vasculitis (2023) Ostendorf L, Burns M, Wagner DL, Enghard P, Amann KU, Mei H, Eckardt KU, et al. Journal article Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance (2022) Simons G, Janssen EM, Veldwijk J, Disantostefano RL, Englbrecht M, Radawski C, Valor-Mendez L, et al. Journal article Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort (2022) Kuster S, Jordan S, Elhai M, Held U, Steigmiller K, Bruni C, Cacciapaglia F, et al. Journal article
1 2 3